NATCO PHARMA LIMITED (INDIA)
Gefitinib-geftinat
“Gefitinib” is the Drug / Molecule content in "Geftinat". Gefitinib is an anilinoquinazoline. It attaches to epidermal growth factor receptors (EGFRs), thereby blocking the attachment of EGF and the activation of tyrosine kinase. It targets the mutant protein in the cancerous cells and destroys them.
Indication
Gefitinib is used for the treatment of Non-Small Cell Lung Cancer.
Note
SCHEDULE H PRESCRIPTION DRUG - CAUTION
To be supplied on the prescription of a Cancer Specialist / Institution / Hospital only.
Precaution
- Geftinat is a prescription drug and should be used under proper medical guidance and advice.
- Contraindicated in pregnancy and lactation.
Updated On Oct 15, 2019 by Admin
Strength
250 mg Tablets
Packing
1 x 30 Tablets (Strip)
Storage
Store in a cool, dry place, protected from sunlight and moisture.
Was this page helpful?
Related Products
CIPLA LTD. (INDIA)
Pirfenex
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Gefitinib-geftinat
Astra Zeneca
Iressa-geftinat
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)